Paul Thacker and Charles Seife provide an update on the ongoing battles over transparency in science, writing for the PLOS Biologue blog. While transparency is important for accountability and the public trust, some have begun to argue that requests for personal communications between companies and researchers have gone too far.
-
How about a major overhaul of the whole system and kicking pharmaceutical companies from drug development altogether? Public funding worked well for the development of many great things, including the internet so I see no reason why pharma should be allowed to continue to pollute science.
